Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2020 07:30 ET | Source: Kura Oncology, Inc.

Kura Oncology Receives Fast Track Designation for Tipifarnib in T-Cell Lymphomas

– Second Fast Track designation for tipifarnib further highlights potential for tipifarnib to address unmet need for patients – – Company plans to initiate a registration-directed trial of tipifarnib...